author-photo

Emmanuel Plouvier

113

Papers

3615

Citations

Citation Trend

Filter By

Papers (78) Sort By

Journal Conference Others

Expanded Access Program of GRASPA for treatment of patients with acute lymphoblastic leukemia unable to receive other form of L-Asparaginase: A status update (NCT02197650).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Different outcome of T cell acute lymphoblastic leukemia with ă translocation t(11;14) treated in two consecutive children leukemia ă group EORTC trials

2016
Show All
- Source
- Cite
- Save
Citations (0)
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials.

2016 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
t(12;21)/ETV6-RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol

2015 Haematologica
Show All
- Source
- Cite
- Save
Citations (9)
P-253 – Un diagnostic tiré par les cheveux !

2015 Archives De Pediatrie
Show All
- Source
- Cite
- Save
Citations (0)
Expanded Access Program of Graspa for Treatment of Patients with Acute Lymphoblastic Leukemia Unable to Receive Other Form of L-Asparaginase - a Status Update (NCT02197650)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic relevance of CD200/BTLA deletions in pediatric precursor-B cell acute lymphoblastic leukemia treated according to the EORTD-CLG 58951 protocol

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)